- TWD1.80bn
- TWD1.45bn
- TWD445.68m
- 54
- 25
- 57
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,766 | 1,142 | 1,409 | 1,477 | 446 |
Cost of Revenue | |||||
Gross Profit | 519 | 235 | 393 | 594 | 203 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,630 | 1,174 | 1,272 | 1,247 | 465 |
Operating Profit | 136 | -32.1 | 137 | 230 | -19.4 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 117 | -101 | 101 | 332 | -10.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 116 | -102 | 96.8 | 283 | -33 |
Net Income Before Extraordinary Items | |||||
Net Income | 116 | -102 | 96.8 | 283 | -33 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 116 | -102 | 96.8 | 283 | -33 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.46 | -1.32 | 1.1 | 3.5 | -0.38 |
Dividends per Share |